Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 1/20 | 0.42 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.40 |
| ▸ | SLC5A1 | P13866 | 5/20 | 0.39 |
| ▸ | SLC5A2 | P31639 | 5/20 | 0.39 |
| ▸ | LDHA | P00338 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | MRGPRX4 | Q96LA9 | 3/20 | 0.37 |
| ▸ | XDH | P47989 | 1/20 | 0.37 |
| ▸ | RXRA | P19793 | 1/20 | 0.36 |
| ▸ | RXRB | P28702 | 1/20 | 0.36 |
| ▸ | RXRG | P48443 | 1/20 | 0.36 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23488442 | 0.81 | TYMP (0.49) | TYMPLGALS8SLC5A1SLC5A2TDP1 | |
| SCHEMBL23488274 | 0.79 | TDP1 (0.49) | TYMPLGALS8SLC5A1SLC5A2TDP1 | |
| SCHEMBL23488679 | 0.79 | XDH (0.47) | TYMPLGALS8TDP1MRGPRX4XDH | |
| SCHEMBL23488550 | 0.78 | MAOB (0.43) | TYMPLGALS8SLC5A1SLC5A2TDP1 | |
| SCHEMBL23488464 | 0.78 | MAOB (0.43) | TYMPLGALS8SLC5A1SLC5A2TDP1 | |
| SCHEMBL23488164 | 0.78 | TDP1 (0.52) | TYMPLGALS8TDP1XDHRXRA | |
| SCHEMBL23488114 | 0.78 | NPC1 (0.54) | TYMPTDP1MRGPRX4XDHRXRA | |
| SCHEMBL23488630 | 0.78 | XDH (0.48) | TYMPLGALS8SLC5A1SLC5A2TDP1 | |
| SCHEMBL23488472 | 0.78 | MAOB (0.43) | TYMPLGALS8SLC5A1SLC5A2TDP1 | |
| SCHEMBL23488668 | 0.76 | CHRNB2 (0.51) | TYMPLGALS8SLC5A1SLC5A2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210170033-A1 | NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | SANOFI (FR) | 2021-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210170033-A1 | NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | GPR119, SLC2A8, SLC2A4 | TYMP 2235/4885LGALS8 61/4885SLC5A1 9/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.